Skip to Main Content

Author Details

Wendell D Jones
Department of Bioinformatics and Clinical Systems
2006
43
22
PMIDPaper TitleJournal TitlePublished Year
36177381<i>PLK3</i> amplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancer.NAR Cancer2022
36177381<i>PLK3</i> amplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancer.NAR Cancer2022
35768876Deep oncopanel sequencing reveals within block position-dependent quality degradation in FFPE processed samples.Genome Biol2022
35680918Ultra-deep multi-oncopanel sequencing of benchmarking samples with a wide range of variant allele frequencies.Sci Data2022
35418127Ultra-deep sequencing data from a liquid biopsy proficiency study demonstrating analytic validity.Sci Data2022
35680918Ultra-deep multi-oncopanel sequencing of benchmarking samples with a wide range of variant allele frequencies.Sci Data2022
35768876Deep oncopanel sequencing reveals within block position-dependent quality degradation in FFPE processed samples.Genome Biol2022
35418127Ultra-deep sequencing data from a liquid biopsy proficiency study demonstrating analytic validity.Sci Data2022
33064055Dexrazoxane enhances efficacy of all-<i>trans</i> retinoic acid in acute myeloid leukemia patient blast cells and cell lines.Leuk Lymphoma2021
35475002Advancing NGS quality control to enable measurement of actionable mutations in circulating tumor DNA.Cell Rep Methods2021
33846644Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology.Nat Biotechnol2021
34308277A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples.iScience2021
33863366A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency.Genome Biol2021
33863344Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions.Genome Biol2021
33064055Dexrazoxane enhances efficacy of all-<i>trans</i> retinoic acid in acute myeloid leukemia patient blast cells and cell lines.Leuk Lymphoma2021
34789871Reporting guidelines for human microbiome research: the STORMS checklist.Nat Med2021
34504346Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.Nat Biotechnol2021
35475002Advancing NGS quality control to enable measurement of actionable mutations in circulating tumor DNA.Cell Rep Methods2021
33846644Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology.Nat Biotechnol2021
33863366A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency.Genome Biol2021
33863344Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions.Genome Biol2021
34789871Reporting guidelines for human microbiome research: the STORMS checklist.Nat Med2021
34504346Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.Nat Biotechnol2021
34308277A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples.iScience2021
32156016RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers.Cancers (Basel)2020
32143562CNV Radar: an improved method for somatic copy number alteration characterization in oncology.BMC Bioinformatics2020
32156016RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers.Cancers (Basel)2020
32143562CNV Radar: an improved method for somatic copy number alteration characterization in oncology.BMC Bioinformatics2020
30883751Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma.J Pathol2019
31182547CBP/p300 Drives the Differentiation of Regulatory T Cells through Transcriptional and Non-Transcriptional Mechanisms.Cancer Res2019
31061401Deleterious effects of formalin-fixation and delays to fixation on RNA and miRNA-Seq profiles.Sci Rep2019
30883751Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma.J Pathol2019
31182547CBP/p300 Drives the Differentiation of Regulatory T Cells through Transcriptional and Non-Transcriptional Mechanisms.Cancer Res2019
31061401Deleterious effects of formalin-fixation and delays to fixation on RNA and miRNA-Seq profiles.Sci Rep2019
29710874Applicability of Precision Medicine Approaches to Managing Hypertension in Rural Populations.J Pers Med2018
29892687Clonal lineage of high grade serous ovarian cancer in a patient with neurofibromatosis type 1.Gynecol Oncol Rep2018
30386679Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.Oncoimmunology2018
29402501HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy.Gynecol Oncol2018
29710874Applicability of Precision Medicine Approaches to Managing Hypertension in Rural Populations.J Pers Med2018
29892687Clonal lineage of high grade serous ovarian cancer in a patient with neurofibromatosis type 1.Gynecol Oncol Rep2018
30386679Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.Oncoimmunology2018
29402501HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy.Gynecol Oncol2018
28508029A B-Cell Gene Signature Correlates With the Extent of Gluten-Induced Intestinal Injury in Celiac Disease.Cell Mol Gastroenterol Hepatol2017
28508029A B-Cell Gene Signature Correlates With the Extent of Gluten-Induced Intestinal Injury in Celiac Disease.Cell Mol Gastroenterol Hepatol2017
29220036The international MAQC Society launches to enhance reproducibility of high-throughput technologies.Nat Biotechnol2017
29220036The international MAQC Society launches to enhance reproducibility of high-throughput technologies.Nat Biotechnol2017
27534558Blood-Borne RNA Correlates with Disease Activity and IFN-Stimulated Gene Expression in Systemic Lupus Erythematosus.J Immunol2016
26311224Expression profile of COL2A1 and the pseudogene SLC6A10P predicts tumor recurrence in high-grade serous ovarian cancer.Int J Cancer2016
27562560Editor's Highlight: Dose-Response Analysis of RNA-Seq Profiles in Archival Formalin-Fixed Paraffin-Embedded Samples.Toxicol Sci2016
27534558Blood-Borne RNA Correlates with Disease Activity and IFN-Stimulated Gene Expression in Systemic Lupus Erythematosus.J Immunol2016
  • 1 - 50 of 86

Recommended Authors

Travers Ching
Adaptive Biotechnologies
Career Start Year 2014
Number of shared co-authors 1
Chen Wang
Center for Individualized Medicine, Mayo Clinic
Career Start Year 2011
Number of shared co-authors 3
Asha A Nair
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 4
Darragh G McArt
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 0
Stephen R Piccolo
Brigham Young University
Career Start Year 2008
Number of shared co-authors 2
Xinmin Li
University of California los angeles
Career Start Year 2008
Number of shared co-authors 0
Qiyuan Li
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 1
Mark J Dunning
The Medical School, The University of Sheffield
Career Start Year 2007
Number of shared co-authors 0
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 3
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 7
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 5
Wayne Yu
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Career Start Year 2005
Number of shared co-authors 2
Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 1
Andy G Lynch
University of St Andrews
Career Start Year 2004
Number of shared co-authors 3
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 1
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 6
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 3
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 1
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 12
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 2
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 7
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 3
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 2
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 3
Kevin R Coombes
Medical College of Georgia
Career Start Year 1990
Number of shared co-authors 2
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 4
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 14

Collaborators

Weida Tong
National Center for Toxicological Research
Co-authored papers 15
Ming Shi
Co-authored papers 12
James C Willey
Co-authored papers 10
Rebecca Kusko
Immuneering Corporation
Co-authored papers 9
Russell D Wolfinger
SAS Institute
Co-authored papers 8
Baitang Ning
Co-authored papers 8
Joshua Xu
Co-authored papers 8
Huixiao Hong
Co-authored papers 8
Wenjun Bao
SAS Institute Inc Cary
Co-authored papers 7
Christopher E Mason
Feil Family Brain and Mind Research Institute.
Co-authored papers 7
Quan-Zhen Li
Co-authored papers 7
Hong Fang
National Center for Toxicological Research (NCTR)
Co-authored papers 7
Andreas Scherer
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Co-authored papers 6
Donald J Johann
Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences
Co-authored papers 6
Cesare Furlanello
Bruno Kessler Foundation
Co-authored papers 6
Zhenqiang Su
Co-authored papers 6
Charles Wang
Co-authored papers 6
Yaron Turpaz
Pte. Ltd.
Co-authored papers 5
Liang Zhang
Co-authored papers 5
Anne Bergstrom Lucas
Co-authored papers 5
Danielle Thierry-Mieg
Co-authored papers 5
Federico Goodsaid
Co-authored papers 5
Roger Perkins
Co-authored papers 5
Tieliu Shi
Co-authored papers 5
Jean Thierry-Mieg
Co-authored papers 5
Roderick V Jensen
Virginia Tech
Co-authored papers 5
Zhiguang Li
Co-authored papers 4
Tim R Mercer
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Co-authored papers 4
Kelci Miclaus
Co-authored papers 4
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Co-authored papers 4
Release 1.2